AI Proteins
PrivateLast Round
Series A
Nov 19, 2025
Total Funding Raised
$59.7M
Momentum Score
25 /100
Company Overview
AI Proteins is a biotechnology company that utilizes an artificial intelligence-based design and a high-throughput drug discovery platform to create synthetic miniproteins for a variety of therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AI Proteins Comps
Public and private peers based on sector, stage, and business model.
AI Proteins Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 19, 2025 | ||||
| Seed | Nov 3, 2022 |
AI Proteins Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mission BioCapital | Series A |
| Santé Ventures | Series A |
| Cobro Ventures | Series A, Seed |
| LightChain Capital | Series A, Seed |
AI Proteins Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AI Proteins's valuation, stock price, and market status.
